News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-07-02-2014
Volume10
Issue 7

Frontage Labs Plans Expansion of CMC Facility

Frontage Labs will expand its CMC facility in Exton, PA.

Frontage Labs reported plans to expand its chemistry, manufacturing, and controls (CMC) facility in Exton, PA. The expansion includes increased incremental capacity to existing services and will also provide Frontage with additional room for future growth.

The renovation plan involves two phases. Initial improvements, which include two analytical laboratories and 8000 square feet of office space, will begin in mid-2014, with completion scheduled for the end of September. The second phase, which includes additional clinical trial manufacturing space for solid, semi-solid, and sterile pharmaceutical products and packaging, labeling, and distribution functions, will be implemented at the beginning of 2015. Following the completion of this expansion in mid-2015, Frontage expects to increase its CMC workforce and capacity by more than 50%.

Source:Frontage Labs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content